Oncology & Cancer

PET/CT imaging of prostate cancer proves accurate biopsy guide

Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy ...

Oncology & Cancer

Blood test predicts success of neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear ...

Cardiology

Amyloid scan of the heart predicts major cardiac events

Amyloid build-up is commonly talked about in relation to Alzheimer's disease, but amyloidosis can be found throughout the body. An excessive accumulation of these insoluble proteins could cause a heart attack or even death. ...

Alzheimer's disease & dementia

Cloud-based neuroimaging analysis could aid Alzheimer's diagnosis

Alzheimer's disease remains a chronic, incurable neurodegenerative disease and a worldwide health concern. Equally as important as developing comprehensive diagnostic tests is finding a means of normalizing all the ensuing ...

Oncology & Cancer

Hybrid scanner combines five molecular imaging technologies

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all-in-one imaging of both tissue models and live subjects, ...

Oncology & Cancer

PET/CT captures hidden source of neuroendocrine cancer

The origin of cancer is often obscured by metastases—tumors that have already spread to other tissues. This is especially the case for neuroendocrine tumors (NETs), a malignancy of nerve cells scattered throughout various ...

Oncology & Cancer

Theranostic PET takes on both ovarian and prostate cancer

A first-in-human study revealed at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells ...

page 5 from 10